Zydus Lifesciences Ltd (BOM:532321)
₹ 1050.35 -8.2 (-0.77%) Market Cap: 1.06 Til Enterprise Value: 1.04 Til PE Ratio: 27.99 PB Ratio: 5.42 GF Score: 95/100

Q4 2021 Cadila Healthcare Ltd Earnings Call Transcript

May 27, 2021 / 12:00PM GMT
Release Date Price: ₹626.7 (-0.19%)
Operator

Ladies and gentlemen, Good day, and welcome to Cadila Healthcare Limited Q4 FY '21 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded. (Operator Instructions) I would now like to hand the conference over to Mr. Ganesh Nayak, COO and Executive Director from Cadila Healthcare. Thank you, and over to you, Mr. Nayak.

Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Thank you. Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter and the year ended March 31, 2021. I do wish that you and your families are safe and well. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Harish Sadana, Chief Strategy Officer; and Mr. Vishal Gor, Senior Vice President, Corporate Finance.

We continue to be at the forefront in the fight against the pandemic. While the uncertainty and challenges related to the pandemic are evolving, we stay committed to serve the demand across our markets on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot